Systematic review of mesotherapy: a novel avenue for the treatment of hair loss

AK Gupta, S Polla Ravi, T Wang… - Journal of …, 2023 - Taylor & Francis
Mesotherapy is a technique by which lower doses of therapeutic agents and bioactive
substances are administered by intradermal injections to the skin. Through intradermal …

Menopause, skin and common dermatoses. Part 1: hair disorders

E Kamp, M Ashraf, E Musbahi… - Clinical and …, 2022 - academic.oup.com
Menopause, which usually occurs between the age of 45 and 55 years, is associated with
falling oestrogen levels due to ovarian follicle depletion. The impact on the cardiovascular …

[HTML][HTML] Male androgenetic alopecia

W Cranwell, R Sinclair - 2015 - europepmc.org
Male androgenetic alopecia (MAA) is the most common form of hair loss in men, affecting 30-
50% of men by age 50. MAA occurs in a highly reproducible pattern, preferentially affecting …

[HTML][HTML] Coupling of fused deposition modeling and inkjet printing to produce drug loaded 3D printed tablets

LA Junqueira, AG Tabriz, FJ Raposo, LR Carobini… - Pharmaceutics, 2022 - mdpi.com
In the current study, we have coupled Fused Deposition Modelling (FDM) for the fabrication
of plain polyvinyl alcohol (PVA) tablets followed by dispensing of minoxidil ethanolic …

Low-dose oral minoxidil for treatment of androgenetic alopecia and telogen effluvium in a pediatric population: A descriptive study

B de Nicolas-Ruanes… - Journal of the …, 2022 - pubmed.ncbi.nlm.nih.gov
Low-dose oral minoxidil for treatment of androgenetic alopecia and telogen effluvium in a
pediatric population: A descriptive study Low-dose oral minoxidil for treatment of …

[HTML][HTML] Psychometric evaluation of an adult post-COVID-19 symptom tool: a development and validation study

PY Kuo, PH Chen, SF Tsai, WL Lin, CT Hung… - Scientific Reports, 2024 - nature.com
The objective of this study was aimed to develop and validate an instrument for post-COVID-
19 symptoms in adults. Data were collected from adults with a previous COVID-19 diagnosis …

Clinical efficacy and safety of low‐dose oral minoxidil versus topical solution in the improvement of androgenetic alopecia: a randomized controlled trial

A Asilian, A Farmani, M Saber - Journal of Cosmetic …, 2024 - Wiley Online Library
Background Topical minoxidil is the recommended first‐line pharmacologic treatment for
male and female pattern hair loss. However, low‐dose oral minoxidil has been used off …

Comprehensive review of oral minoxidil in alopecia

JD Modha, YS Pathania - Journal of Cosmetic Dermatology, 2022 - Wiley Online Library
Background There have been various treatment modalities available for alopecia in the form
of topical and systemic with a variable response. The compliance of the patients is important …

Discovery of potential neuroprotective agents against paclitaxel-induced peripheral neuropathy

YF Chen, CH Wu, LH Chen, HW Lee… - Journal of Medicinal …, 2022 - ACS Publications
Chemotherapy-induced neurotoxicity is a common adverse effect of cancer treatment. No
medication has been shown to be effective in the prevention or treatment of chemotherapy …

[HTML][HTML] Male androgenetic alopecia

L Asfour, W Cranwell, R Sinclair - Endotext [Internet], 2023 - ncbi.nlm.nih.gov
Male androgenetic alopecia (MAA) is the most common form of hair loss in men, affecting 30-
50% of men by age 50. MAA occurs in a highly reproducible pattern, preferentially affecting …